SCHEMBL1718903

SCHEMBL1718903

O=C(Nc1cccnc1Cl)c1nn2c(C(F)(F)F)cc(-c3ccco3)nc2c1Cl

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.69
ALDH1A1 P00352 15/20 0.62
MAPT P10636 7/20 0.59
CASP1 P29466 6/20 0.59
GAA P10253 4/20 0.59
RAB9A P51151 2/20 0.54
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
HSD17B10 Q99714 5/20 0.51
HPGD P15428 8/20 0.51
NPSR1 Q6W5P4 4/20 0.51
CYP1A2 P05177 2/20 0.51
CYP3A4 P08684 2/20 0.51
CYP2C9 P11712 2/20 0.51
CYP2C19 P33261 2/20 0.51
TDP1 Q9NUW8 1/20 0.49
CASP7 P55210 4/20 0.48
POLB P06746 2/20 0.48
ESR1 P03372 1/20 0.48
ESR2 Q92731 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1718130 0.85 MAPT (0.61) KDM4EALDH1A1MAPTCASP1GAA
SCHEMBL1718270 0.85 KDM4E (0.68) KDM4EALDH1A1MAPTCASP1GAA
SCHEMBL1720229 0.85 KDM4E (0.73) KDM4EALDH1A1MAPTCASP1GAA
SCHEMBL1718037 0.83 KDM4E (0.70) KDM4EALDH1A1MAPTCASP1GAA
SCHEMBL1718627 0.83 MAPT (0.59) KDM4EALDH1A1MAPTCASP1GAA
SCHEMBL1718508 0.82 KDM4E (0.69) KDM4EALDH1A1MAPTCASP1GAA
SCHEMBL2543331 0.82 ALDH1A1 (0.74) KDM4EALDH1A1MAPTCASP1GAA
SCHEMBL1719500 0.82 KDM4E (0.68) KDM4EALDH1A1MAPTCASP1GAA
SCHEMBL1719012 0.82 KDM4E (0.71) KDM4EALDH1A1MAPTCASP1GAA
SCHEMBL1718032 0.82 KDM4E (0.71) KDM4EALDH1A1MAPTCASP1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506196-B1 PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS ICAGEN INC (US) 2012-01-18 EP claimed
EP-1506196-B1 PYRAZOLOPYRIMIDINES AS SODIUM CHANNEL INHIBITORS ICAGEN INC (US) 2012-01-18 EP disclosed